Form 4 for ADMA ADMA BIOLOGICS, INC.
Accepted 2021-10-26 00:00:00 ET · period of report 2021-10-25 · accession 0001140361-21-035381 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-26 | 2021-10-25 | ADMA | Grossman Jerrold B | Dir | P - Purchase | $1.00 | +100.0K | 260.9K | +62% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-25 | P | A | 100,000 | $1.00 | 260,864 | D | — | — | (F1) Represents a purchase from the underwriters in the October 2021 public offering of the issuer. |